| Quantity | 20 nmol, 50 nmol, 100 nmol, 200 nmol | ~0.6x10^6 cells per 1ml of freezing medium (vial) | 2 vials | 1mg | 20 nmol, 50 nmol, 100 nmol, 200 nmol |
| Description | The product SIRGT96552WQ-2OMe is a type of small interfering RNA (siRNA) that targets Gm156 gene and regulates the expression of gene. The siRNA interferes with the expression of Gm156 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The The product SIRGT96552WQ-2OMe is a type of small interfering RNA (siRNA) that targets Gm156 gene and regulates the expression of gene. The siRNA interferes with the expression of Gm156 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2_-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.... Read More | iNeu™ human keratinocytes are derived from human dermal fibroblasts, using a feeder-free, serum-free, genetic-free, virus-free induced pluripotent stem cell (iPSC) line, and have fully defined proprietary induction and maturation conditions. iNeu™ cells can be cultured in a monolayer andiNeu™ human keratinocytes are derived from human dermal fibroblasts, using a feeder-free, serum-free, genetic-free, virus-free induced pluripotent stem cell (iPSC) line, and have fully defined proprietary induction and maturation conditions. iNeu™ cells can be cultured in a monolayer and can express different biomarkers, such as Cytokeratin-18. iNeu™ can be used under mature conditions, co-culture conditions (used with fibroblasts, melanocytes or other epidermal subtypes), and short-term functional characterization studies.... Read More | Creative Biolabs offers a range of recombinant cell lines for Immunotherapy discovery and development. | This product is recombinant Human GLUT1 in VLPs form. This product is produced from mammalian cells by co-expressing the retroviral structural core polyprotein (gag) and the target membrane protein. MP-VLPs display highly-expressed copies of membrane proteins in their native conformation, providing This product is recombinant Human GLUT1 in VLPs form. This product is produced from mammalian cells by co-expressing the retroviral structural core polyprotein (gag) and the target membrane protein. MP-VLPs display highly-expressed copies of membrane proteins in their native conformation, providing an alternative to membrane protein stable cell lines, membrane preparations, detergent-solubilized proteins and other membrane protein preparation strategies. MP-VLPs can be used for a wide range of applications in antibody production, antibody discovery, antibody characterization, binding assays and functional assays.... Read More | The product SIRGT99541WQ-LNA is a type of small interfering RNA (siRNA) that targets A2m gene and regulates the expression of gene. The siRNA interferes with the expression of A2m gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA isThe product SIRGT99541WQ-LNA is a type of small interfering RNA (siRNA) that targets A2m gene and regulates the expression of gene. The siRNA interferes with the expression of A2m gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.... Read More |